Diastika Biotekindo Tbk. vs Cipta Sarana Medika Tbk. — how do they compare? Diastika Biotekindo Tbk. trades at Rp126 (market cap 514.17B, 1.22M 24h volume), while Cipta Sarana Medika Tbk. trades at Rp63 (market cap 158.12B, 8.21M 24h volume). The key difference: Diastika Biotekindo Tbk. is far larger — about 3.3× Cipta Sarana Medika Tbk.'s market cap, and Cipta Sarana Medika Tbk. is more actively traded (8.21M versus 1.22M). Which is the better fit depends on your goals.
| CHEK | DKHH | |
|---|---|---|
Market Cap | 514.17B | 158.12B |
Volume | 1.22M | 8.21M |
Lot | 12.25K | 82.15K |
Turnover | 155.6M | 515.2M |
Average Price | 127.05 | 62.72 |
Value | 155.6M | 515.2M |
Indicative Equilibrium Price | 126 | 63 |
Indicative Equilibrium Volume | 503 | 1.33K |
Trailing returns across standard periods
Latest headlines on both assets
PT Diastika Biotekindo Tbk. (The Company) was established in Jakarta based on Deed No. 33 dated July 20, 1989 made before Mrs. Sitti Marjami Soepangat, SH. notary in Jakarta. The Company started its commercial activities in years 1986. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on CHEK →PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →